Innate Pharma SA: Innate Pharma Announces Its Participation in Upcoming Investor Conferences

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced members of its executive team are scheduled to participate in the upcoming conferences

Related Keywords

France ,United States ,Rockville ,New York ,Miami ,Florida ,French ,Arthur Rouill ,Sonia Quaratino ,Henry Wheeler ,Euronext ,Linkedin ,French Financial Markets Authority ,Nasdaq ,Exchange Commission ,Goldman Sachs ,Astrazeneca ,Company Annual Report On Form ,Regulatory News ,Euronext Paris ,Chief Executive Officer ,Executive Vice President ,Chief Medical Officer ,Yannis Morel ,Chief Operating Officer ,Arvind Sood ,Global Healthcare Conference ,Annual Global Healthcare Conference ,Annual Immune Cell Engager Virtual Conference ,European Healthcare Summit Lyon ,Engager Therapeutics ,Innate Pharma ,Private Securities Litigation Reform Act ,Risk Factors ,Universal Registration Document ,Annual Report ,Ihr Portfolio ,